Jinghua Pharmaceutical Group Co Ltd
SZSE:002349
Income Statement
Earnings Waterfall
Jinghua Pharmaceutical Group Co Ltd
Revenue
|
1.5B
CNY
|
Cost of Revenue
|
-770.8m
CNY
|
Gross Profit
|
691.7m
CNY
|
Operating Expenses
|
-423.1m
CNY
|
Operating Income
|
268.6m
CNY
|
Other Expenses
|
-37.5m
CNY
|
Net Income
|
231.1m
CNY
|
Income Statement
Jinghua Pharmaceutical Group Co Ltd
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
710
N/A
|
654
-8%
|
624
-5%
|
578
-7%
|
559
-3%
|
565
+1%
|
620
+10%
|
780
+26%
|
858
+10%
|
915
+7%
|
916
+0%
|
882
-4%
|
967
+10%
|
1 036
+7%
|
1 066
+3%
|
1 121
+5%
|
1 144
+2%
|
1 156
+1%
|
1 249
+8%
|
1 355
+8%
|
1 371
+1%
|
1 375
+0%
|
1 371
0%
|
1 157
-16%
|
1 120
-3%
|
1 128
+1%
|
1 143
+1%
|
1 281
+12%
|
1 311
+2%
|
1 315
+0%
|
1 325
+1%
|
1 358
+3%
|
1 432
+5%
|
1 508
+5%
|
1 564
+4%
|
1 573
+1%
|
1 581
+0%
|
1 577
0%
|
1 518
-4%
|
1 512
0%
|
1 463
-3%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(501)
|
(441)
|
(409)
|
(361)
|
(339)
|
(329)
|
(361)
|
(483)
|
(522)
|
(538)
|
(514)
|
(448)
|
(501)
|
(537)
|
(544)
|
(565)
|
(582)
|
(590)
|
(651)
|
(708)
|
(726)
|
(715)
|
(725)
|
(738)
|
(644)
|
(674)
|
(660)
|
(695)
|
(705)
|
(697)
|
(732)
|
(739)
|
(776)
|
(827)
|
(843)
|
(847)
|
(861)
|
(857)
|
(824)
|
(781)
|
(771)
|
|
Gross Profit |
209
N/A
|
213
+2%
|
215
+1%
|
217
+1%
|
220
+2%
|
236
+7%
|
259
+10%
|
297
+15%
|
336
+13%
|
377
+12%
|
402
+6%
|
434
+8%
|
466
+7%
|
499
+7%
|
521
+5%
|
556
+7%
|
562
+1%
|
566
+1%
|
597
+5%
|
646
+8%
|
644
0%
|
660
+2%
|
646
-2%
|
419
-35%
|
476
+13%
|
453
-5%
|
483
+7%
|
586
+21%
|
607
+3%
|
618
+2%
|
592
-4%
|
619
+4%
|
656
+6%
|
681
+4%
|
720
+6%
|
726
+1%
|
720
-1%
|
720
+0%
|
694
-4%
|
731
+5%
|
692
-5%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(171)
|
(181)
|
(180)
|
(178)
|
(182)
|
(187)
|
(198)
|
(221)
|
(236)
|
(247)
|
(256)
|
(257)
|
(285)
|
(287)
|
(301)
|
(292)
|
(356)
|
(362)
|
(378)
|
(344)
|
(342)
|
(352)
|
(731)
|
(540)
|
(998)
|
(1 011)
|
(741)
|
(367)
|
(537)
|
(549)
|
(507)
|
(454)
|
(494)
|
(490)
|
(476)
|
(501)
|
(485)
|
(496)
|
(460)
|
(428)
|
(423)
|
|
Selling, General & Administrative |
(161)
|
(172)
|
(172)
|
(147)
|
(177)
|
(180)
|
(190)
|
(181)
|
(228)
|
(238)
|
(251)
|
(196)
|
(244)
|
(246)
|
(255)
|
(244)
|
(297)
|
(306)
|
(310)
|
(292)
|
(295)
|
(298)
|
(302)
|
(434)
|
(431)
|
(427)
|
(432)
|
(294)
|
(317)
|
(320)
|
(364)
|
(352)
|
(381)
|
(392)
|
(375)
|
(393)
|
(387)
|
(393)
|
(370)
|
(353)
|
(359)
|
|
Research & Development |
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(43)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
(9)
|
(37)
|
(32)
|
(42)
|
(42)
|
(80)
|
(85)
|
(88)
|
(91)
|
(48)
|
(57)
|
(59)
|
(70)
|
(70)
|
(75)
|
(79)
|
(69)
|
(81)
|
(85)
|
(82)
|
(84)
|
(59)
|
(69)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(32)
|
0
|
0
|
0
|
(39)
|
0
|
0
|
0
|
(42)
|
0
|
0
|
0
|
(22)
|
0
|
|
Other Operating Expenses |
(10)
|
(9)
|
(7)
|
(4)
|
(5)
|
(7)
|
(7)
|
(1)
|
(8)
|
(9)
|
(5)
|
(3)
|
(42)
|
(41)
|
(47)
|
8
|
(59)
|
(55)
|
(59)
|
13
|
(14)
|
(12)
|
(387)
|
4
|
(483)
|
(496)
|
(217)
|
7
|
(164)
|
(171)
|
(74)
|
7
|
(38)
|
(19)
|
(32)
|
15
|
(12)
|
(20)
|
(5)
|
7
|
4
|
|
Operating Income |
38
N/A
|
33
-14%
|
35
+8%
|
39
+9%
|
38
-1%
|
49
+27%
|
62
+26%
|
76
+23%
|
101
+33%
|
130
+29%
|
146
+12%
|
176
+21%
|
181
+2%
|
212
+17%
|
220
+4%
|
263
+19%
|
206
-22%
|
205
-1%
|
220
+7%
|
303
+38%
|
302
0%
|
308
+2%
|
(85)
N/A
|
(121)
-43%
|
(523)
-332%
|
(558)
-7%
|
(258)
+54%
|
219
N/A
|
70
-68%
|
69
-2%
|
85
+23%
|
165
+94%
|
162
-2%
|
190
+17%
|
245
+28%
|
225
-8%
|
235
+4%
|
224
-5%
|
234
+5%
|
302
+29%
|
269
-11%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(7)
|
0
|
0
|
(3)
|
3
|
4
|
9
|
16
|
25
|
21
|
19
|
21
|
8
|
6
|
2
|
(3)
|
(2)
|
0
|
5
|
3
|
12
|
5
|
5
|
10
|
(1)
|
10
|
(3)
|
(13)
|
(4)
|
(8)
|
35
|
41
|
34
|
39
|
16
|
21
|
43
|
52
|
48
|
31
|
42
|
|
Non-Reccuring Items |
0
|
0
|
0
|
4
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(90)
|
0
|
0
|
(3)
|
(18)
|
0
|
(1)
|
2
|
(390)
|
0
|
7
|
7
|
(144)
|
3
|
4
|
3
|
(27)
|
(1)
|
(1)
|
(1)
|
2
|
(0)
|
(0)
|
(0)
|
(5)
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
(9)
|
(9)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
4
|
12
|
18
|
11
|
12
|
12
|
6
|
4
|
5
|
6
|
6
|
9
|
7
|
5
|
5
|
46
|
44
|
45
|
44
|
1
|
(5)
|
(7)
|
(9)
|
0
|
(5)
|
(5)
|
(0)
|
1
|
3
|
2
|
1
|
0
|
(2)
|
(2)
|
(2)
|
2
|
(1)
|
(0)
|
(1)
|
1
|
(2)
|
|
Pre-Tax Income |
35
N/A
|
35
+1%
|
45
+28%
|
51
+14%
|
53
+4%
|
65
+22%
|
77
+18%
|
97
+26%
|
130
+34%
|
156
+20%
|
171
+9%
|
202
+18%
|
194
-4%
|
224
+15%
|
227
+2%
|
217
-5%
|
248
+14%
|
250
+1%
|
265
+6%
|
289
+9%
|
309
+7%
|
304
-2%
|
(86)
N/A
|
(501)
-480%
|
(529)
-6%
|
(546)
-3%
|
(254)
+54%
|
64
N/A
|
72
+13%
|
67
-7%
|
125
+88%
|
179
+43%
|
194
+8%
|
227
+17%
|
258
+14%
|
250
-3%
|
277
+11%
|
275
-1%
|
281
+2%
|
330
+17%
|
309
-6%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(9)
|
(11)
|
(11)
|
(15)
|
(17)
|
(15)
|
(19)
|
(23)
|
(24)
|
(29)
|
(25)
|
(24)
|
(25)
|
(27)
|
(29)
|
(30)
|
(30)
|
(28)
|
(33)
|
(32)
|
(35)
|
(24)
|
(25)
|
(29)
|
(26)
|
(36)
|
(36)
|
(29)
|
(29)
|
(39)
|
(42)
|
(47)
|
(50)
|
(38)
|
(41)
|
(41)
|
(38)
|
(53)
|
(50)
|
|
Income from Continuing Operations |
34
|
35
|
36
|
41
|
42
|
50
|
60
|
82
|
111
|
133
|
147
|
174
|
170
|
199
|
202
|
190
|
219
|
220
|
235
|
260
|
277
|
273
|
(122)
|
(524)
|
(553)
|
(575)
|
(280)
|
28
|
36
|
38
|
96
|
140
|
152
|
179
|
208
|
212
|
236
|
235
|
243
|
276
|
259
|
|
Income to Minority Interest |
(5)
|
(5)
|
(3)
|
(1)
|
1
|
(0)
|
(1)
|
(4)
|
(4)
|
(6)
|
(5)
|
(8)
|
(15)
|
(19)
|
(19)
|
(15)
|
(16)
|
(14)
|
(18)
|
(30)
|
(40)
|
(42)
|
(34)
|
131
|
146
|
156
|
201
|
83
|
78
|
75
|
41
|
21
|
19
|
6
|
(7)
|
(0)
|
(3)
|
2
|
(4)
|
(29)
|
(28)
|
|
Net Income (Common) |
30
N/A
|
30
+2%
|
33
+9%
|
40
+20%
|
43
+8%
|
50
+16%
|
58
+18%
|
78
+34%
|
106
+36%
|
128
+20%
|
142
+12%
|
165
+16%
|
155
-6%
|
181
+16%
|
183
+1%
|
175
-4%
|
204
+16%
|
206
+1%
|
217
+5%
|
230
+6%
|
237
+3%
|
231
-3%
|
(156)
N/A
|
(394)
-153%
|
(407)
-4%
|
(419)
-3%
|
(79)
+81%
|
111
N/A
|
114
+2%
|
113
-1%
|
138
+22%
|
161
+17%
|
171
+6%
|
185
+8%
|
201
+9%
|
212
+5%
|
233
+10%
|
237
+2%
|
239
+1%
|
248
+4%
|
231
-7%
|
|
EPS (Diluted) |
0.06
N/A
|
0.06
N/A
|
0.06
N/A
|
0.07
+17%
|
0.07
N/A
|
0.07
N/A
|
0.08
+14%
|
0.09
+13%
|
0.13
+44%
|
0.16
+23%
|
0.18
+13%
|
0.2
+11%
|
0.19
-5%
|
0.22
+16%
|
0.22
N/A
|
0.21
-5%
|
0.24
+14%
|
0.24
N/A
|
0.25
+4%
|
0.27
+8%
|
0.28
+4%
|
0.27
-4%
|
-0.2
N/A
|
-0.48
-140%
|
-0.5
-4%
|
-0.51
-2%
|
-0.09
+82%
|
0.14
N/A
|
0.14
N/A
|
0.14
N/A
|
0.17
+21%
|
0.2
+18%
|
0.21
+5%
|
0.23
+10%
|
0.25
+9%
|
0.26
+4%
|
0.29
+12%
|
0.29
N/A
|
0.29
N/A
|
0.3
+3%
|
0.28
-7%
|